Evidence map›Paper›PMID 41284927›Full record

ArticleGenomics, proteomics & bioinformatics2026

scATAnno: Automated Cell Type Annotation for Single-cell ATAC-seq Data.

Yijia Jiang, Zhirui Hu, Feng Lu, Allen W Lynch, Junchen Jiang, Alexander Zhu, Ziqi Zeng, Yi Zhang, Gongwei Wu, Yingtian Xie and 7 more

Abstract read
In one paragraph

Article in Genomics, proteomics & bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Yijia JiangDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.ORCID 0000-0002-0239-6999
Zhirui HuGladstone Institute of Data Science and Biotechnology, San Francisco, CA 94158, USA.ORCID 0000-0001-6352-4854
Feng LuDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.ORCID 0009-0002-4460-4503
Allen W LynchDepartment of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.ORCID 0000-0003-0796-3232
Junchen JiangThe Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.ORCID 0009-0002-7259-2896
Alexander ZhuThe Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.ORCID 0009-0003-1042-7710
Ziqi ZengThe Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.ORCID 0009-0004-1774-6148
Yi ZhangDepartment of Neurosurgery, Duke University, Durham, NC 27708, USA.ORCID 0000-0002-7453-6188
Gongwei WuDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.ORCID 0000-0002-2509-2381
Yingtian XieDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.ORCID 0000-0003-0206-457X
Rong LiDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.ORCID 0009-0000-1046-9580
Ningxuan ZhouDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.ORCID 0000-0002-7623-2276
Cliff A MeyerDepartment of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.ORCID 0000-0002-8321-2839
Paloma CejasDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.ORCID 0000-0002-2090-7748
Myles BrownDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.ORCID 0000-0002-8213-1658
Henry W LongDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.ORCID 0000-0001-6849-6629
Xintao QiuDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.ORCID 0000-0002-8560-7017

Funding

Use of Organotypic and Mammary Gland Models to Investigate the Outcomes of ClonalP01CA080111 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI BRUGGE, JOAN SIEFERT · 1999 to 2018
$36.0M
Steroid Metabolism in Castration-Resistant Prostate CancerP01CA163227 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Steven P. Balk · 2013 to 2026
$25.0M
Tissue and Pathology CoreP01CA250959 · NCI · DANA-FARBER CANCER INST · PI SICINSKI, PETER · 2020 to 2024
$8.6M
Resolving single-cell brain regulatory elements with bulk data supervised modelsR01MH123178 · NIMH · J. DAVID GLADSTONE INSTITUTES · PI POLLARD, KATHERINE S. · 2020 to 2023
$2.4M
NCI NIH HHS P01 CA080111NCI NIH HHS P01 CA163227NCI NIH HHS P01 CA250959NIMH NIH HHS R01 MH123178
6 · The paper itself

Abstract

Recent advances in single-cell epigenomic techniques have increased the demand for single-cell assay for transposase-accessible chromatin using sequencing (scATAC-seq) analysis. One key analytical task is to determine cell type identity based on epigenetic data. Here, we introduce scATAnno, a Python package designed to automatically annotate scATAC-seq data using large-scale scATAC-seq reference atlases. This workflow generates reference atlases from publicly available datasets, enabling accurate cell type annotation by integrating query data with reference atlases without the use of single-cell RNA sequencing (scRNA-seq) data. To enhance annotation accuracy, we incorporated k-nearest neighbors (KNN)-based and weighted distance-based uncertainty scores to effectively detect cell populations within the query data that are distinct from all cell types in the reference data. We compared and benchmarked scATAnno against five other published cell annotation approaches, demonstrating its superior performance across multiple datasets and metrics. We further showcased the utility of scATAnno across multiple datasets, including peripheral blood mononuclear cells (PBMCs), triple-negative breast cancer (TNBC), and basal cell carcinoma (BCC), and demonstrated that scATAnno accurately annotates cell types across diverse biological conditions. Overall, scATAnno is a useful tool for scATAC-seq reference atlas construction and cell type annotation and can facilitate the interpretation of new scATAC-seq datasets in complex biological systems. scATAnno is publicly available at https://scatanno-main.readthedocs.io/.

Indexed as

Chromatin Immunoprecipitation SequencingMolecular Sequence AnnotationSingle-Cell AnalysisSoftwareEpigenomicsHumansCell annotationReference atlasscATAC-seqSingle-cell epigenomicsUncertainty score

Identifiers

PMID41284927
PMCPMC13568823

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.